Advanced Filters
noise

One or multiple investigational sites, Luxembourg Clinical Trials

A listing of One or multiple investigational sites, Luxembourg clinical trials actively recruiting patients volunteers.

Found 65,195 clinical trials
W Wenfei Tan, M.D.,Ph.D

Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery.

65 years of age All Phase 4
P Patrizia Rovere Querini, PhD,MD

Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly

Ageing is characterised by a change in body composition with a parallel decrease in muscle mass and an increase and central redistribution of fat. When drastically exacerbated, these two processes culminate in a condition known as sarcopenic obesity (SO). SO is characterised by the coexistence of obesity and sarcopenia (i.e. …

65 - 99 years of age All Phase N/A
m mohamed G. Zeinhom, MD

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

Along with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever small vessel stroke patients treated with clopidogrel and aspirin assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age All Phase 3

Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)

The primary purpose of this study is to evaluate the safety and tolerability of ION356.

2 - 17 years of age Male Phase 1
K Kang Yu, MD

Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia

The goal of this observational study is to establish a digital diagnosis and treatment system for sarcopenia, integrating research outcomes into a unified approach encompassing a digital vaccine (early warning screening model), digital drug (intervention model associated with pathogenesis), and digital rehabilitation (preventive system combining early warning and treatment). This …

45 years of age All Phase N/A
G Giovanni Capretti, Dr.

Italian Registry of Minimally Invasive Pancreatic Surgery

Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes

18 years of age All Phase N/A
P Pim de Graaf, PhD

Trilateral Retinoblastoma: Incidence and Outcomes

Patients with heritable retinoblastoma are at risk to develop an intracranial brain tumor, which is often fatal. The investigators intend to look at the incidence and survival of trilateral retinoblastoma (which is a brain tumor that can either be located in the pineal gland or elsewhere in the brain) in …

years of age All Phase N/A
M Momchilo Vuyisich, PhD

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

years of age All Phase N/A
H Heena Olalde

Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last seen well

18 years of age All Phase N/A

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.

18 years of age All Phase 3

Simplify language using AI